IP Library Assignment 019262/0274
Patent Assignment
Reel/Frame 019262/0274

Corrective Assignment to Correct the Assignors Lu and Simon Should Not Have Been Identified. Document Dates for Each Remaining Assignor Need to Be Corrected as Well. Previously Recorded on Reel 019255 Frame 636. Assignor(S) Hereby Confirms the Assignment of Assignor's Interest.

Recorded: 2007-05-08 Pages: 9
Assignors
BRUNS, ROBERT F., JR
Executed: 2004-04-09
GUILLON, CHRISTOPHE D.G.
Executed: 2004-04-05
HEINDEL, NED D.
Executed: 2004-04-05
KOPPEL, GARY A.
Executed: 2004-04-05
MILLER, MARVIN J.
Executed: 2004-04-06
Assignee
SERENIX PHARMACEUTICALS, LLC.
111 RESEARCH DRIVE, BETHLEHEM, PENNSYLVANIA, 18015
Covered Property (1)
Beta-Lactamyl Vasopressin V1A Antagonists
Patent: 7,268,125 →
Application: 11/442,788 →
Publication: US 2006/0217364
Related Assignments (4)
Other recorded transfers of the patent in this record — the chain of ownership.
Assignment of Assignor's Interest May 7, 2007
From: GUILLON, CHRISTOPHE D.G.; HEINDEL, NED D.; LU, SHIFANG; SIMON, NEAL G.
To: SERENIX PHARMACEUTICALS, LLC.
Reel/Frame 019255/0636 →
Merger May 7, 2007
From: SERENIX PHARMACEUTICALS, LLC.
To: AZEVAN PHARMACEUTICALS, INC.
Reel/Frame 019255/0657 →
Confirmatory License Jun 11, 2008
From: AZEVAN PHARMACEUTICALS, INC.
To: NATIONAL INSTITUTES OF HEALTH (NIH), U.S. DEPT. OF HEALTH AND HUMAN SERVICES (DHHS), U.S. GOVERNMENT
Reel/Frame 021078/0602 →
Confirmatory License Jan 6, 2017
From: AZEVAN PHARMACEUTICALS, INC.
To: NATIONAL INSTITUTES OF HEALTH (NIH), U.S. DEPT. OF HEALTH AND HUMAN SERVICES (DHHS), U.S. GOVERNMENT
Reel/Frame 041273/0157 →